Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8394127 | 0.85 | LMNA (0.32) | LMNAL3MBTL1TDP1 | |
| SCHEMBL319673 | 0.80 | — | — | |
| SCHEMBL1270184 | 0.74 | LMNA (0.44) | LMNA | |
| SCHEMBL18529337 | 0.73 | LMNA (0.44) | LMNAL3MBTL1TDP1 | |
| SCHEMBL578416 | 0.73 | LMNA (0.44) | LMNAL3MBTL1TDP1 | |
| E968 SCHEMBL10956312 | 0.71 | LMNA (0.57) | LMNAL3MBTL1TDP1 | |
| E968 SCHEMBL10956309 | 0.71 | LMNA (0.57) | LMNAL3MBTL1TDP1 | |
| E968 SCHEMBL121807 | 0.71 | — | — | |
| E968 SCHEMBL2723809 | 0.71 | LMNA (0.67) | LMNAL3MBTL1TDP1 | |
| E968 SCHEMBL6729753 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100129385-A1 | IMMUNOGENIC MOLECULES | COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH, THE (AU) | 2010-05-27 | — | — | US | disclosed |
| EP-1861426-A4 | IMMUNOGENIC MOLECULES | QUEENSLAND INST MED RES (AU) | 2008-11-12 | — | — | EP | disclosed |
| EP-1861426-A1 | IMMUNOGENIC MOLECULES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006084319-A1 | IMMUNOGENIC MOLECULES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129385-A1 | IMMUNOGENIC MOLECULES | HLA-DRB1, HLA-C, CD74 | LMNA 4700/4885L3MBTL1 4021/4885TDP1 4277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.